Thrivent Financial for Lutherans Reduces Position in ICU Medical, Inc. (NASDAQ:ICUI)

Thrivent Financial for Lutherans decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 81.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,366 shares of the medical instruments supplier’s stock after selling 23,204 shares during the quarter. Thrivent Financial for Lutherans’ holdings in ICU Medical were worth $845,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ICUI. Covestor Ltd grew its stake in shares of ICU Medical by 86.4% in the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 57 shares during the period. Quadrant Capital Group LLC boosted its holdings in ICU Medical by 210.4% in the third quarter. Quadrant Capital Group LLC now owns 208 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 141 shares during the last quarter. Ronald Blue Trust Inc. boosted its holdings in ICU Medical by 166.3% in the fourth quarter. Ronald Blue Trust Inc. now owns 213 shares of the medical instruments supplier’s stock worth $32,000 after purchasing an additional 133 shares during the last quarter. Bessemer Group Inc. boosted its holdings in ICU Medical by 134.3% in the third quarter. Bessemer Group Inc. now owns 321 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 184 shares during the last quarter. Finally, Point72 Hong Kong Ltd purchased a new stake in ICU Medical in the first quarter worth approximately $94,000. Institutional investors own 93.88% of the company’s stock.

ICU Medical Trading Down 3.6 %

Shares of ICU Medical stock opened at $184.93 on Wednesday. The company’s fifty day simple moving average is $177.21 and its 200-day simple moving average is $170.60. The stock has a market capitalization of $4.45 billion, a PE ratio of -96.32 and a beta of 0.63. ICU Medical, Inc. has a 1-year low of $128.90 and a 1-year high of $212.43. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.62 and a quick ratio of 1.01.

ICU Medical (NASDAQ:ICUI – Get Rating) last posted its quarterly earnings data on Monday, February 27th. The medical instruments supplier reported $1.36 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.14. ICU Medical had a positive return on equity of 6.42% and a negative net margin of 2.00%. The firm had revenue of $578.01 million for the quarter, compared to analysts’ expectations of $578.60 million. As a group, equities analysts anticipate that ICU Medical, Inc. will post 5.63 earnings per share for the current year.

Insider Activity

In related news, VP Virginia Ruth Sanzone sold 250 shares of ICU Medical stock in a transaction on Tuesday, April 11th. The shares were sold at an average price of $175.00, for a total transaction of $43,750.00. Following the transaction, the vice president now owns 4,678 shares in the company, valued at approximately $818,650. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 7.50% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. KeyCorp raised their target price on shares of ICU Medical from $200.00 to $216.00 in a report on Tuesday, May 9th. StockNews.com started coverage on ICU Medical in a research report on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, 51job reissued a “maintains” rating on shares of ICU Medical in a research report on Tuesday, May 9th.

ICU Medical Profile

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.